These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 4137316)

  • 1. Thrombophlebitis. A cardinal symptom of Behçet's syndrome.
    Haim S; Sobel JD; Friedman-Birnbaum R
    Acta Derm Venereol; 1974; 54(4):299-301. PubMed ID: 4137316
    [No Abstract]   [Full Text] [Related]  

  • 2. Decreased fibrinolysis in Behçet's disease.
    Chajek T; Aronowski E; Izak G
    Thromb Diath Haemorrh; 1973 Jun; 29(3):610-8. PubMed ID: 4761829
    [No Abstract]   [Full Text] [Related]  

  • 3. Do hemorheological alterations play any role in the development of thrombotic events in Behçet's disease?
    Vayá A; Ricart J; Todolí J; Micó L; Contreras T; Aznar J
    Clin Hemorheol Microcirc; 2004; 30(3-4):411-4. PubMed ID: 15258375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of factor V Leiden with Behçet's disease.
    Mammo L; Al-Dalaan A; Bahabri SS; Saour JN
    J Rheumatol; 1997 Nov; 24(11):2196-8. PubMed ID: 9375883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormalities of T-cell subsets in Behçet's syndrome.
    Lim SD; Haw CR; Kim NI; Fusaro RM
    Arch Dermatol; 1983 Apr; 119(4):307-10. PubMed ID: 6220679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of leptin level and Ob gene polymorphism in patients with Behcet's disease.
    Okudan N; Acar H; Gökbel H; Mevlitoğlu I; Sari F
    Arch Dermatol Res; 2006 Aug; 298(3):127-30. PubMed ID: 16786343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiphosphatidylserine-prothrombin complex antibodies in 3 patients with Behçet disease involving superficial vein thrombophlebitis.
    Kawakami T; Yamazaki M; Mizoguchi M; Soma Y
    Arch Dermatol; 2009 Feb; 145(2):171-5. PubMed ID: 19221262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasma coagulation and fibrinolysis parameters in patients with vascular Behçet's disease, and analysis of the multimeric structure of von Willebrand factor (vWF)].
    Kagawa H; Okubo S
    Ryumachi; 1993 Oct; 33(5):416-23. PubMed ID: 8256164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the fibrinolytic system in Behçet's disease?
    Asbeck F; Meyer-Boernecke D; van de Loo J
    Haemostasis; 1977; 6(5):303-9. PubMed ID: 598751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum interleukin 18 and tumour necrosis factor-alpha levels are increased in Behcet's disease.
    Oztas MO; Onder M; Gurer MA; Bukan N; Sancak B
    Clin Exp Dermatol; 2005 Jan; 30(1):61-3. PubMed ID: 15663506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Behçet's disease and vascular malformations: double etiology of recurrent thrombophlebitis].
    Rouget JP; Goudemand J; Bouqueau F; Caron C; Jaillard J
    Sem Hop; 1983 Jun; 59(22):1661-4. PubMed ID: 6308786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High lipoprotein (a) levels as a thrombogenic risk factor in Behçet's disease.
    Orem A; Değer O; Memiş O; Calişkan K; Cimşit G
    Ann Rheum Dis; 1994 May; 53(5):351-2. PubMed ID: 8017992
    [No Abstract]   [Full Text] [Related]  

  • 13. Baseline and stimulated thyroid functions in Behçet's disease.
    Akdeniz S; Colak S; Tuzcu AK; Bahceci M; Harman M
    J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):878-9. PubMed ID: 16898920
    [No Abstract]   [Full Text] [Related]  

  • 14. Haemostasis in patients with Behçet's disease.
    Demirer S; Sengül N; Yerdel MA; Tüzüner A; Ulus AT; Gürler A; Bergqvist D; Siegbahn A; Karacagil S
    Eur J Vasc Endovasc Surg; 2000 Jun; 19(6):570-4. PubMed ID: 10873722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating endothelial cells in Behçet's disease with cerebral thrombophlebitis.
    Camoin-Jau L; Kone-Paut I; Chabrol B; Sampol J; Dignat-George F
    Thromb Haemost; 2000 Apr; 83(4):631-2. PubMed ID: 10780331
    [No Abstract]   [Full Text] [Related]  

  • 16. Decreased nitric oxide and increased platelet aggregation levels in patients with Behçet's disease.
    Yapişlar H; Aydogan S; Borlu M; Ascioglu O
    Thromb Res; 2007; 119(4):461-5. PubMed ID: 16806408
    [No Abstract]   [Full Text] [Related]  

  • 17. Endothelial cell activation and hypercoagulability in ocular Behçet's disease.
    Probst K; Fijnheer R; Rothova A
    Am J Ophthalmol; 2004 May; 137(5):850-7. PubMed ID: 15126149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum interleukin-8 as a serologic marker of activity in Behçet's disease.
    Gür-Toy G; Lenk N; Yalcin B; Aksaray S; Alli N
    Int J Dermatol; 2005 Aug; 44(8):657-60. PubMed ID: 16101867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulated activated platelets and increased platelet reactivity in patients with Behçet's disease.
    Akar S; Ozcan MA; Ateş H; Gürler O; Alacacioglu I; Ozsan GH; Akkoç N; Ozkan S; Demirkan F; Onen F
    Clin Appl Thromb Hemost; 2006 Oct; 12(4):451-7. PubMed ID: 17000890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Activated protein C resistance in Behçet disease].
    Guermazi S; M'Rad S; Lamloum M; Houman MH; Hamza M; Ben Dridi M; Miled M; Dellagi K
    Pathol Biol (Paris); 1998 Dec; 46(10):791-5. PubMed ID: 9922996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.